Finance

Beta
Lists
3401:TYO
Teijin Ltd
Â¥1,628.00
-0.85%
(-14.00) 1D
Jun 4, 3:19:27 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 3401...
Open
Â¥1,635
High
Â¥1,640
Low
Â¥1,602
Mkt. cap
322.27B
Avg. vol.
1.07M
Volume
456.70K
Dividend
3.07%
Quarterly dividend
Â¥12
Ex-dividend date
Sep 29, 2025
52-wk high
Â¥1,773
52-wk low
Â¥1,095
EPS
-Â¥456
Shares outstanding
191.79M
No. of employees
20K
Open
Â¥1,635
High
Â¥1,640
Low
Â¥1,602
Mkt. cap
322.27B
Avg. vol.
1.07M
Volume
456.70K
Dividend
3.07%
Quarterly dividend
Â¥12
Ex-dividend date
Sep 29, 2025
52-wk high
Â¥1,773
52-wk low
Â¥1,095
EPS
-Â¥456
Shares outstanding
191.79M
No. of employees
20K
News stories
From sources across the web
Profile
Teijin Limited is a Japanese chemical, pharmaceutical and information technology company. Its main fields of operation are high-performance fibers such as aramid, carbon fibers & composites, healthcare, films, resin & plastic processing, polyester fibers, products converting and IT products. The company is listed on the first section of the Tokyo Stock Exchange and is a constituent of the Nikkei 225 stock index. As of March 2014, the Teijin Group comprises 151 companies, 56 in Japan and 95 overseas. Teijin is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
About Teijin Ltd
CEOAkimoto Uchikawa | Jun Suzuki
Employees20.3K
FoundedJun 17, 1918
Headquarters-
SectorCommodity chemical
Websiteteijin.com
Last report
May 11, 2026
Fiscal period
Q4 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
213.30B / 204.90B
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
243.12B
207.93B
208.84B
213.30B
Cost of goods sold
187.23B
199.31B
151.75B
167.80B
Cost of revenue
187.23B
199.31B
151.75B
167.80B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
52.57B
54.35B
48.52B
72.70B
Operating expense
53.60B
65.00B
48.36B
62.50B
Total operating expenses
240.82B
264.30B
200.11B
230.30B
Operating income
2.29B
-56.38B
8.72B
-17.00B
Other non operating income
-
1.00M
-1.00M
100.00M
EBT including unusual items
61.00M
-55.82B
-115.00M
-18.20B
EBT excluding unusual items
61.00M
-55.82B
8.30B
-18.20B
Income tax expense
631.00M
-1.66B
4.06B
10.80B
Effective tax rate
1,034.43%
2.98%
-3,533.91%
-59.34%
Other operating expenses
1.03B
10.65B
-155.00M
-10.20B
Net income
-740.00M
-54.10B
-4.14B
-29.00B
Net profit margin
-0.30%
-26.02%
-1.98%
-13.60%
Earnings per share
-
-
-
-
Interest and investment income
1.36B
1.00B
808.00M
-
Interest expense
-4.86B
-1.36B
-1.47B
-800.00M
Net interest expenses
-3.50B
-357.00M
-664.00M
-800.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
17.60B
-40.32B
23.50B
-2.83B
Gain or loss from assets sale
109.00M
50.64B
10.92B
-11.40B
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer